Page last updated: 2024-10-23

azelaic acid and Acute Myelogenous Leukemia

azelaic acid has been researched along with Acute Myelogenous Leukemia in 2 studies

nonanedioic acid : An alpha,omega-dicarboxylic acid that is heptane substituted at positions 1 and 7 by carboxy groups.

Research Excerpts

ExcerptRelevanceReference
"Molm-13 cells, a type of acute myeloid leukemia cell, were chosen and injected into the device and fittingly captured by cell traps."1.48Real-time detection and monitoring of the drug resistance of single myeloid leukemia cells by diffused total internal reflection. ( Jin, YX; Liang, L; Yang, Y; Zhou, FL; Zhu, XQ, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Zhang, D1
Luo, Z1
Jin, Y1
Chen, Y1
Yang, T1
Yang, Q1
Wu, B1
Shang, Y1
Liu, X1
Wei, Y1
Zhou, F1
Liang, L1
Jin, YX1
Zhu, XQ1
Zhou, FL1
Yang, Y1

Other Studies

2 other studies available for azelaic acid and Acute Myelogenous Leukemia

ArticleYear
Azelaic Acid Exerts Antileukemia Effects against Acute Myeloid Leukemia by Regulating the Prdxs/ROS Signaling Pathway.
    Oxidative medicine and cellular longevity, 2020, Volume: 2020

    Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Bone Marrow; Cell Line, Tumor; Cell Prolife

2020
Real-time detection and monitoring of the drug resistance of single myeloid leukemia cells by diffused total internal reflection.
    Lab on a chip, 2018, 05-15, Volume: 18, Issue:10

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Dicarboxylic Acids; Drug Monitoring; Drug Re

2018